Medical Devices: A Closer Look
June 23rd, 2009
With all the chatter about health care reform coming out of Washington, now may be a great time to consider health care-related investments.
Most investors look to big pharmaceutical companies for health care exposure. That was the old way of profiting from the medical arena. While these stocks are usually considered blue chips, they face a toxic combination of competition from generic drug makers and their own empty new-drug pipelines. Think about it: When was the last time Merck (MRK) or Pfizer (PFE) released a true blockbuster drug? Answer: It’s been a while.
The Euro’s Demise Has Been Set in Motion: Are you protected?
"Nationalism will emerge. Healthier countries will not see fit to spend their hard earned money to bail out their less responsible neighbors."
CLICK HERE to get your Free E-Book, “Why It’s Curtains for the Euro”
Most Comments